Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, March 15, 2024.
Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.
Conformal Medical this week reported "encouraging" results for its left atrial appendage occlusion device. Fast Five hosts Danielle Kirsh and Sean Whooley discuss what the device does and what doctors think about the device.
Autonomix has completed its first procedures in its pancreatic cancer ablation trial. Learn what the trial will assess, what the technology does and how optimistic executives are.
Axonics won CE mark approval for its fourth-generation rechargeable sacral neuromodulation system. Whooley talks about what the device does and some of the other news Axonics has had recently.
SafeGuard Surgical won an FDA breakthrough nod for its biodegradable stent. Hear more about the stent, which has backing from an NFL quarterback.
Edwards reported "excellent" outcomes with its latest Sapien TAVR study. The Fast Five hosts talk about some of the data points that stuck out.
All content for Fast Five Medtech News Podcast is the property of MassDevice and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, March 15, 2024.
Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.
Conformal Medical this week reported "encouraging" results for its left atrial appendage occlusion device. Fast Five hosts Danielle Kirsh and Sean Whooley discuss what the device does and what doctors think about the device.
Autonomix has completed its first procedures in its pancreatic cancer ablation trial. Learn what the trial will assess, what the technology does and how optimistic executives are.
Axonics won CE mark approval for its fourth-generation rechargeable sacral neuromodulation system. Whooley talks about what the device does and some of the other news Axonics has had recently.
SafeGuard Surgical won an FDA breakthrough nod for its biodegradable stent. Hear more about the stent, which has backing from an NFL quarterback.
Edwards reported "excellent" outcomes with its latest Sapien TAVR study. The Fast Five hosts talk about some of the data points that stuck out.
A high-ranking BD executive is set to retire; J&J’s Biosense Webster begins trial for Laminar LAA
Fast Five Medtech News Podcast
11 minutes 56 seconds
1 year ago
A high-ranking BD executive is set to retire; J&J’s Biosense Webster begins trial for Laminar LAA
Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, February 28, 2024.
Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.
Mainstay Medical has raised $125 million for its neurostimulation technology. Fast Five hosts Danielle Kirsh and Sean Whooley talk about the company's plans for the funds and what the implant does.
Philips has launched its new Azurion neuro biplane system for neurovascular interventions. Learn more about what Azurion does and how it helps workflows.
Know Labs unveiled its wearable, non-invasive CGM set for FDA submission. Whooley details the technology and how it works.
J&J's Biosense Webster has started its trial for the recently acquired Laminar left atrial appendage elimination device. Hear more about the study details and an explanation of what Laminar is.
A high-ranking executive at BD has announced plans to retire. The Fast Five hosts talk about who is leaving, if the company named a successor and some of the work the executive has achieved in their tenure.
Fast Five Medtech News Podcast
Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, March 15, 2024.
Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast.
Conformal Medical this week reported "encouraging" results for its left atrial appendage occlusion device. Fast Five hosts Danielle Kirsh and Sean Whooley discuss what the device does and what doctors think about the device.
Autonomix has completed its first procedures in its pancreatic cancer ablation trial. Learn what the trial will assess, what the technology does and how optimistic executives are.
Axonics won CE mark approval for its fourth-generation rechargeable sacral neuromodulation system. Whooley talks about what the device does and some of the other news Axonics has had recently.
SafeGuard Surgical won an FDA breakthrough nod for its biodegradable stent. Hear more about the stent, which has backing from an NFL quarterback.
Edwards reported "excellent" outcomes with its latest Sapien TAVR study. The Fast Five hosts talk about some of the data points that stuck out.
